# Real-world Immunogenicity of Anti-IL5/5a Antibody

> **NCT07567690** · — · ACTIVE_NOT_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Asthma
- Immunogenicity
- Biologics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07567690
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-19
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07567690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07567690, "Real-world Immunogenicity of Anti-IL5/5a Antibody". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07567690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*